Syncom Formulations (India) Limited
SYNCOMF
Rank in Stocks
#16628
Established in 1985 and based in Indore, India, Syncom Formulations (India)... Established in 1985 and based in Indore, India, Syncom Formulations (India) Limited specializes in the development, marketing, and sale of a wide array of finished pharmaceutical products. The company provides an extensive portfolio addressing numerous therapeutic categories, including but not limited to pain relief, infectious diseases, cardiovascular health, mental well-being, respiratory ailments, and nutritional deficiencies, alongside specific treatments for conditions like gout and erectile dysfunction, encompassing both generic and specialized medicines. These medicinal preparations are available in various formats such as tablets, capsules, oral liquids, injectables (both liquid and dry vial), dry syrups, topical ointments, inhalers, and herbal formulations. In addition to its core pharmaceutical business, Syncom Formulations also engages in commodity trading and property leasing. The company serves the domestic Indian market and actively exports its products globally.
Share Price
$0.2139503
Last synced: 2026-11-09
Market Cap
$201.11M
Change (1 day)
0.05%
Change (1 year)
18.30%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Syncom Formulations (India) Limited (SYNCOMF)
Category
Healthcare
EPS for Syncom Formulations (India) Limited (SYNCOMF)
EPS as of June 2026 TTM: $0.01
According to Syncom Formulations (India) Limited's latest financial reports, its current EPS (TTM) is $0.01. At the end of 2025 the company had an EPS of $0.01, an increase over its 2024 EPS of 0.00.
EPS history for Syncom Formulations (India) Limited from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.01 | -4.00% |
| 2025 | $0.01 | 109.38% |
| 2024 | 0.00 | 18.52% |
| 2023 | 0.00 | -15.63% |
| 2022 | 0.00 | -37.25% |
| 2021 | $0.01 | 112.50% |
| 2020 | 0.00 | 20.00% |
| 2019 | 0.00 | 11.11% |
| 2018 | 0.00 | -10.00% |
| 2017 | 0.00 | 0.00% |
| 2016 | 0.00 | -4.76% |
| 2015 | 0.00 | 5.00% |
| 2014 | 0.00 | 53.85% |
| 2013 | 0.00 | 44.44% |
| 2012 | 0.00 | 800.00% |
| 2011 | 0.00 | -96.97% |
| 2010 | 0.00 | 37.50% |
| 2009 | 0.00 | -42.86% |
| 2008 | 0.00 | -8.70% |
| 2007 | 0.00 | -20.69% |
| 2006 | $0.01 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 67,622.92% |
DE
|
|
| $6.08 | 63,208.33% |
DE
|
|
| $1.55 | 16,052.08% |
JP
|
|
| $3.66 | 38,025.00% |
CH
|
|
| $0.45 | 4,587.50% |
IL
|
Questions about Syncom Formulations (India) Limited's earnings per share (EPS)
What is Syncom Formulations (India) Limited's earnings per share (EPS)?
Syncom Formulations (India) Limited's earnings per share (EPS) over the last twelve months is $0.01, as of Jun 2026.
What was Syncom Formulations (India) Limited's earnings per share (EPS) in 2025?
In 2025, Syncom Formulations (India) Limited's earnings per share (EPS) was $0.01, compared with 0.00 in 2024.
How has Syncom Formulations (India) Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Syncom Formulations (India) Limited's earnings per share (EPS) was highest in 2025 ($0.01) and lowest in 2024 (0.00).
How does Syncom Formulations (India) Limited's earnings per share (EPS) compare with similar companies?
Syncom Formulations (India) Limited's earnings per share (EPS) ($0.01) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.